期刊文献+

酪氨酸羟化酶基因载体-pCMVTH 质粒的构建及在大鼠骨骼肌内的表达 被引量:2

RECONSTRUCTION OF TYROSINE HYDROXYLASE GENE VECTOR-pCMVTH AND EXPRESSION IN RAT MUSCLE CELLS
下载PDF
导出
摘要 为用转基因方法治疗巴金森氏病大鼠模型,本研究采用分子克隆技术,将合成多巴胺的关键酶-酪氨酸羟化酶(TH)的基因,克隆进入以巨细胞病毒CMV为启动子的载体质粒内,经限制性内切酶定位分析证实该重组的DNA质粒的可靠性。携带TH基因的PCMVTH质粒以LIPO-FECTIN介导,在培养的原代骨骼肌细胞中高效表达。本研究为进一步用转基因的细胞植入脑内以治疗巴金森氏病打下一定基础。 The purpose of this study was to determine whether the plasmid pCMVTH which reconstructed was able to show expression in rat muscle cells. We used tyrosine hydroxylasegene, which was from the plasmid of pKSTH as a transgene and cytomegalovirus (CMV),which was from the plasmid of pCMVLacZ as a cellular promoter to do subcloning. Theplasmid pCMVTH was identified by analysis of restriction endonuclease. Primary rat muscleCells were trans feeted with pCMVTH by lipofectin. About 30% myoblasts and myotubeshaving been cultured for 2 days showed expression of tyrosine hydroxylase gene wiht immunohistochmical staining. Our results may serve as a basis for in gene therapy inParkinson's disease by tranferring tyrosine hydroxylase gene into brain tissues.
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 1995年第4期342-346,共5页 Chinese Journal of Histochemistry and Cytochemistry
关键词 酪氨酸羟化酶 DNA质粒重组 原代骨骼肌细胞 大鼠巴金森氏病 Tyrosine hydroxylase gene pCMVTH Primary muscle cells RatParkinson's disease model
  • 相关文献

同被引文献12

  • 1王克权,张进禄,徐群渊,鲁强.BIN—1型巴金森氏病大鼠模型旋转记录仪的研制[J].医疗设备信息,1995,10(4):1-2. 被引量:6
  • 2徐群渊,田竟生,张进禄,杨慧,郑少鹏,刘玉军.基因治疗巴金森氏病大鼠模型的实验研究[J].神经解剖学杂志,1996,12(2):95-102. 被引量:8
  • 3[1]Fabbrini G,Juncos J,Mouradian MM,et al.Levodopa ph armacokinetic mechanisms and motor fluctuations in Parkinson's disease[J].Ann Neurol,1987,21(4):370-6 .
  • 4[4]Beck KD,Valverde J,Alexi T,et al.Mesencephalic dopaminergic neurons protect ed by GDNF from axotomy-induced degeneration in the adult brain[J]. Nat ure,1995 26,373(6512):339-41.
  • 5[5]Hoffer BJ,Hoffman A,Bowenkamp K, et al.Glial cell line-derived neur otrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo [J].Neurosci Lett,1994,182(1):107-11.
  • 6[8]John D E,Robert H R.Dopamine synthesis,uptake,metabolism,and recepto rs:rele vance to gene therapy of Parkinson's disease[J].Exp Neurol,1997,144(1):4-9.[ ZK)
  • 7[10]Jiao S,Gurevich V,Wollf J A,et al.Long-term correction of rat mode l of Parkinson's disease by gene therapy[J]. Nature,1993,362(6419):450-453.
  • 8[11]Lin LH,Doherty DH,Lile JD,et al.GDNF:A glial cell line-derived neu rotrophi c factor for midbrain dopaminergic neurons[J].Science,1993,260(5111):1130-113 2.
  • 9[12]Choi-lundberg DL, Bohn MC. Ontogeny and distribution of glia cell li ne-derived neurotrophic factor(GDNF)mRNA in rat[J].Science Res Dev Brain Res, 1995,85(1):80-88.
  • 10[13]Choi-lundbeg DL,Lin Q, Chang Y N,et al.Dopaminergic neurons protec t ed from degeneration by GDNF gene therapy[J].Science,1997,275(5301):838-841.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部